Korea Green Cross Corporation, the nation’s foremost vaccine developer

Now it’s time to meet one of Korea’s noted companies. This week I bring you a story about Korea Green Cross Corporation. Considered the nation’s foremost provider of comprehensive healthcare services and manufacturer of pharmaceutical goods, Green Cross produced in 1971 Korea’s first albumin, the most abundant blood protein. Since then one of Green Cross’s key projects has been the production of blood components and vaccines. In particular, Green Cross has been the unparalleled leader in the development of Korea’s vaccine industry. Recently Green Cross has announced its plan to launch another vaccine development project, which would take the corporation to another level. Here’s Green Cross Vice President Lee Byung-gun to first tell us about the corporation’s recent business plan.